Abu Dhabi’s Department of Health (DoH), the regulator of healthcare in the emirate, signed a Declaration of Collaboration with French healthcare company Sanofi.
Key activities of the agreement include the cooperation to launch a clinical research project and patient recruitment protocol. In relation to hematology and oncology, DoH and Sanofi agreed to pursue the creation of data generation and population research projects for late-stage breast cancer, liquid tumors, and blood disorders.
Furthermore, both organizations will co-create a high-risk population screening project that will support the detection of rare metabolic diseases utilizing Artificial Intelligence (AI) tools.
Additionally, the collaboration will witness the launch of the Supply Chain Academy, an initiative intended to provide and enhance knowledge related to the vaccine supply chain.
The partnership reiterates Abu Dhabi’s ongoing efforts to position itself as a leading life science destination and an innovation hub.
